Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.7.6NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
DV.6.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FK.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
HF.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
HK.31NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
HG.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EG.4.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.9.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FY.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XDBNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GA.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.35NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GM.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.3.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.44NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FU.3.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FV.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GJ.1.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.22.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FE.1.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBL.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.56NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.16.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EG.1.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.49NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBL.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FR.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.17NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.2.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.18.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.15NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EG.14NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.14NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.2.3.12NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.23.2.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EG.5.1.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EG.5.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
HK.28NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.42NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.4.10NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
HK.19NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GR.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EG.1.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.16.21NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.568NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
P.1.13 (Gamma)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.372NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.634NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
C.37.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used